---
title: "Nike, Merck Share Losses Contribute To Dow's 150-Point Drop"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297066449.md"
description: "The Dow Jones Industrial Average dropped 159 points (0.3%) on Wednesday, driven by losses in key components including Nike, Merck, IBM, Goldman Sachs, and Alphabet. Nike shares fell 2.7% and Merck declined 1.8%, contributing significantly to the index's intraday decline."
datetime: "2026-08-26T15:35:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297066449.md)
  - [en](https://longbridge.com/en/news/297066449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297066449.md)
generator: "portal-rs"
---

# Nike, Merck Share Losses Contribute To Dow's 150-Point Drop

This article was automatically generated by MarketWatch using technology from Automated Insights.

Behind negative returns for shares of Nike and Merck, the Dow Jones Industrial Average is down Wednesday morning.

The Dow (Dow Jones Industrial Average) was most recently trading 159 points (0.3%) lower, as shares of Nike (Nike Inc. Cl B) and Merck (Merck & Co. Inc.) are contributing to the blue-chip gauge's intraday decline.

Nike's shares have dropped $1.06, or 2.7%, while those of Merck have fallen $2.81 (1.8%), combining for a roughly 23-point drag on the Dow.

Also contributing significantly to the decline are IBM (International Business Machines Corp.), Goldman Sachs (Goldman Sachs Group Inc.), and Alphabet Inc. Cl A (Alphabet Inc. Cl A).

A $1 move in any of the index's 30 components results in a 5.94-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-26-26 1135ET

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [NKE.US](https://longbridge.com/en/quote/NKE.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [DIA.US](https://longbridge.com/en/quote/DIA.US.md)
- [DDM.US](https://longbridge.com/en/quote/DDM.US.md)
- [UDOW.US](https://longbridge.com/en/quote/UDOW.US.md)
- [DOG.US](https://longbridge.com/en/quote/DOG.US.md)
- [SDOW.US](https://longbridge.com/en/quote/SDOW.US.md)
- [DXD.US](https://longbridge.com/en/quote/DXD.US.md)
- [IBM.US](https://longbridge.com/en/quote/IBM.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [GOOGL.US](https://longbridge.com/en/quote/GOOGL.US.md)
- [GOOG.US](https://longbridge.com/en/quote/GOOG.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Did Nike’s Inventory Cleanup and Strength Push Just Reframe NIKE's (NKE) Investment Narrative?](https://longbridge.com/en/news/297731911.md)
- [Nike Stock Is Down 78% From Its All-Time High. Is This the Once-in-a-Decade Setup for Patient Investors?](https://longbridge.com/en/news/297803393.md)
- [Merck (MRK), Why Is Its Latest Update Raising Bigger Questions?](https://longbridge.com/en/news/298090109.md)
- [JPMorgan Cuts Nike 2027 Earnings Outlook, Flags China, Rising Competition](https://longbridge.com/en/news/297545215.md)
- [India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar](https://longbridge.com/en/news/297935089.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**